{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:47:38Z","timestamp":1783198058540,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Diagnostic Radiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1067\/j.cpradiol.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:21:14Z","timestamp":1562671274000},"page":"417-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Relationship Between MRI Findings and Molecular Subtypes in Women With Breast Cancer"],"prefix":"10.1067","volume":"49","author":[{"given":"Veli S.","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin D.","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aykut","family":"Soyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Tanyeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can Z.","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00fcsun","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/j.cpradiol.2019.07.003_bib0001","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10147-010-0106-1","article-title":"Clinicopathological features and treatment strategy for triple-negative breast cancer","volume":"15","author":"Yamamoto","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-009-0499-6","article-title":"Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response","volume":"119","author":"de Ronde","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jcp.54.1.20","article-title":"Preoperative assessment of prognostic factors in breast cancer","volume":"54","author":"Denley","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0004","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357900701784238","article-title":"Molecular subtypes in breast cancer evaluation and management: Divide and conquer","volume":"26","author":"Peppercorn","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"Prat","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0008","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0009","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","article-title":"Triple negative tumours: A critical review","volume":"52","author":"Reis-Filho","year":"2008","journal-title":"Histopathology"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0010","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2007.13.1748","article-title":"Basal-like breast cancer: A critical review","volume":"26","author":"Rakha","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0011","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basallike breast cancer defined by five biomarkers has superior prognostic value than triple negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0012","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative earlystage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0013","doi-asserted-by":"crossref","unstructured":"Mann RM. ve ark. \/Breast MRI: Guidelines from the European Society of Breast Imaging\/European Radiology 2008; 18: 1307-1317. https:\/\/doi.org\/10.1007\/s00330-008-0863-7. PMID:18389253 PMCID:PMC2441490.","DOI":"10.1007\/s00330-008-0863-7"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0014","unstructured":"American College of Radiology. BI-RADS: Breast Imaging Reporting and Data System 5th ed.Reston, Va, USA: 2013."},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0016","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1148\/radiol.2503081054","article-title":"Triple-negative breast cancer: Correlation between MR imaging and pathologic findings","volume":"250","author":"Uematsu","year":"2009","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0017","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/tbj.12182","article-title":"MR imaging features of triple-negative breast cancers","volume":"19","author":"Sung","year":"2013","journal-title":"Breast J"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0018","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.2392050205","article-title":"Dynamic MR imaging of breast lesions: Correlation with microvessel distribution pattern and histologic characteristics of prognosis","volume":"239","author":"Teifke","year":"2006","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0019","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19930415)71:8<2507::AID-CNCR2820710813>3.0.CO;2-0","article-title":"Pathologic findings from the National Surgical Adjuvant Breast Project B-06: 10-year pathologic and clinical prognostic discriminants","volume":"71","author":"Fisher","year":"1993","journal-title":"Cancer"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clbc.2012.07.002","article-title":"Magnetic resonance imaging features in triple-negative breast cancer: Comparison with luminal and HER2-overexpressing tumors","volume":"12","author":"Costantini","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0021","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2214\/AJR.09.2355","article-title":"Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI","volume":"194","author":"Dogan","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0022","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/tbj.12756","article-title":"MR imaging findings in molecular subtypes of breast cancer according to BIRADS system","volume":"23","author":"Vilar","year":"2017","journal-title":"Breast J"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1148\/radiol.2461062173","article-title":"Mammographic, US and MR imaging phenotypes of familial breast cancer","volume":"246","author":"Schrading","year":"2008","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0024","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00330-012-2425-2","article-title":"Triple negative invasive breast cancer on dynamic contrast enhanced and diffusion weighted MR imaging: Comparison with other breast cancer subtypes","volume":"22","author":"Youk","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0025","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0026","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0027","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0046-8177(95)90119-1","article-title":"Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer","volume":"26","author":"Brown","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1067\/j.cpradiol.2019.07.003_bib0028","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jmri.24884","article-title":"MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes","volume":"42","author":"Blaschke","year":"2015","journal-title":"J Magn Reson Imaging"}],"container-title":["Current Problems in Diagnostic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363018819300659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363018819300659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:45:29Z","timestamp":1759790729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363018819300659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0363018819300659"],"URL":"https:\/\/doi.org\/10.1067\/j.cpradiol.2019.07.003","relation":{},"ISSN":["0363-0188"],"issn-type":[{"value":"0363-0188","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Relationship Between MRI Findings and Molecular Subtypes in Women With Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Diagnostic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/j.cpradiol.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}